183 related articles for article (PubMed ID: 38428860)
21. Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma.
Peng J; Wang WP; Yuan Y; Hu Y; Wang Y; Chen LQ
Ann Thorac Surg; 2015 Jul; 100(1):263-9. PubMed ID: 25980597
[TBL] [Abstract][Full Text] [Related]
22. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
[TBL] [Abstract][Full Text] [Related]
24. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
[TBL] [Abstract][Full Text] [Related]
26. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
27. Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction.
Xu J; Cao J; Wang L; Wang Z; Wang Y; Wu Y; Lv W; Hu J
Sci Rep; 2017 Aug; 7(1):10123. PubMed ID: 28860457
[TBL] [Abstract][Full Text] [Related]
28. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
Goto H; Tokunaga M; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
Gastric Cancer; 2013 Oct; 16(4):590-5. PubMed ID: 23179369
[TBL] [Abstract][Full Text] [Related]
29. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
[TBL] [Abstract][Full Text] [Related]
30. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures.
Duan XF; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Medicine (Baltimore); 2017 Feb; 96(7):e6120. PubMed ID: 28207537
[TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].
Li SM; Li ZY; Ji X
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):288-91. PubMed ID: 23985258
[TBL] [Abstract][Full Text] [Related]
32. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
Front Oncol; 2021; 11():748694. PubMed ID: 34926257
[TBL] [Abstract][Full Text] [Related]
33. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
Zhang Y; Liu D; Zeng D; Chen C
J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
[TBL] [Abstract][Full Text] [Related]
34. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
Lin JX; Wu D; Jiang YM; Chen JY; Lin GT; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Zheng CH; Huang CM
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):853-859. PubMed ID: 36058712
[No Abstract] [Full Text] [Related]
35. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
[TBL] [Abstract][Full Text] [Related]
36. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.
Duan X; Shang X; Tang P; Jiang H; Yu Z
ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799
[TBL] [Abstract][Full Text] [Related]
37. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
[TBL] [Abstract][Full Text] [Related]
38. Can Clinical Stage in the 8
Watanabe H; Hasegawa S; Kumazu Y; Hashimoto I; Komori K; Suematsu H; Kano K; Fujikawa H; Aoyama T; Yamada T; Yukawa N; Yoshikawa T; Rino Y; Saito A; Ogata T; Oshima T
In Vivo; 2023; 37(4):1790-1796. PubMed ID: 37369497
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
Li ZY; Gu YM; Wang WP; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of outcomes after surgery between adenocarcinoma of the esophagogastric junction and lower thoracic esophageal squamous cell cancer].
Fu SJ; Fang WT; Mao T; Feng J; Gu ZT; Chen WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):893-6. PubMed ID: 22990917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
